节点文献
规范化管理在下肢静脉曲张门诊硬化治疗中的应用效果及意义
Standardized management of sclerotherapy in outpatients with lower extremity varicose vein
【摘要】 目的 探讨规范化管理在下肢静脉曲张门诊硬化治疗中的应用效果及意义。方法 选取2015年6月至2016年4月于河北医科大学第一医院血管外科进行下肢静脉曲张硬化治疗的90例患者为研究对象。采用随机数字表法分为对照组(43例)和观察组(47例)。对照组接受常规治疗,观察组接受规范化管理治疗,对治疗后6个月2组患者的大隐静脉主干闭塞率、并发症及不良反应发生率、静脉曲张临床严重程度评分(VCSS)、治疗次数、治疗费用、患者满意度[用慢性静脉功能不全问卷(CIVIQ)评分评价]进行比较分析。结果 治疗后6个月,观察组大隐静脉主干闭塞率高于对照组,并发症及不良反应发生率低于对照组,VCSS评分低于对照组,治疗次数少于对照组,CⅣIQ评分高于对照组,差异有统计学意义[96.7%(59/61)比82.8%(48/58)、17.0%(8/47)比53.5%(23/43)、(1.4±0.7)分比(2.0±0.9)分、(1.03±0.18)次比(1.20±0.40)次、(86±4)分比(80±5)分](P<0.05或P<0.01)。结论 在下肢静脉曲张门诊硬化治疗中实施规范化管理,可提高治疗效果,节约医疗资源,取得良好社会效益。
【Abstract】 Objective To discuss the application effect of standard management of sclerotherapy in outpatients with lower extremity varicose vein.Methods A total of 90 patients with lower extremity varicose vein were enrolled from June 2015 to April 2016 in the First Hospital of Hebei Medical University.The patients were randomly divided into control group(43 cases) and observation group(47 cases).The control group had routine sclerotherapy;the observational group had sclerotherapy with standard management.Great saphenous vein occlusion rate,complication and adverse reaction rate,Venous Clinical Severity Score(VCSS),treatment times,medical cost and chronic venous insufficiency questionnaire(CIVIQ) were analyzed 6 months after therapy.Results In observation group,the great saphenous vein occlusion rate was higher than that in control group;the complication and adverse reaction rate was lower than that in control group;the VCSS was lower than in control group;treatment times were less than that in control group;the CIVIQ score was higher than that in control group[96.7%(59/61) vs 82.8%(48/58),17.0%(8/47) vs 53.5%(23/43),(1.4 ± 0.7) scores vs(2.0 ±0.9)scores,(1.03 ±0.18) times vs(1.20 ±0.40) times,(86 ±4) scores vs(80 ±5) scores],the differences were statistically significant(P < 0.05 or P < 0.01).Conclusion Sclerotherapy with standard management treating lower extremity varicose vein can improve therapeutic effect.
- 【文献出处】 中国医药 ,China Medicine , 编辑部邮箱 ,2017年02期
- 【分类号】R543.6